Exchange: NASDAQ·Updated 07:59 PM EDT
PHAT logo

PHAT Phathom Pharmaceuticals Inc

$6.99
$0.775
(9.99%)
Today
Closed $6.99
$0.043
(0.62%)
After Hours
EarningsOct 29
Mkt Cap$627.79M
Vol1.05M

About PHAT

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
42

Bearish Sentiment

How do you feel about PHAT?

Withermania
$PHAT are people waking up to what a stupid valuation we’re at now? Company will do $1 in earnings next year. Just buy and hold!
10
Morrito23
$PHAT Our short interest has dropped by significant amounts, yet our price has also gone down. I would’ve liked to see price recovery along with short covering, but that is not the case. I’m obviously simplifying the dynamic, but I will admit, not a fan of that.
9
Morrito23
$PHAT Do research, buy low, and have patience. It has tested me many times, but it has paid off as well. I have no doubt this one will join my winners soon.
9
Valueforall
$PHAT I know a lot of us talk a lot of science mumbo jumbo and chart this and that but on a friyay let’s keep it simple. Isn’t our ultimate goal to have attained enough shares at a reasonable price so that we can all one day just get out of our chairs after looking at the screen and be able to shake our hips and dangle our fingers like this? Rip nitin. 🍀 Nepal
9
Morrito23
$PHAT A good amount of short covering happened after the drop. Almost 2 million shares. So low $8’s proved to be a good place for shorts to start covering. Let’s see how hungry the other 11 million are. Right now I’m still waiting to see if we truly break the 9’s with good volume.
9
Withermania
$PHAT this team needs to make some updates when possible around the prior authorization dynamic. Scripts on IQVIA look solid as we’re trending towards 365k-370k for Q3. There needs to be some catalyst to move this thing other than Q3 earnings. I’ll just keep buying under $9 in the meantime. I’d have to think larger pharma player could navigate this issue more effectively as they probably already have some agentic/digital innovation tool to handle this friction. Get it done PHAT leadership!
9
investpapaya
$PHAT A great value + growth stock! Nice price dislocation at the moment. Pure negative price action pressure. Solid company. Good news behind the scenes. Decent entry/hold/build.
8
Withermania
$PHAT this walk down is insane. lol. Company will be doing $1 in earnings in 2027. Trading at soon to be 1x future sales, and a PE of 7x next years earnings. Growing 70% YoY. I’m just going to load the M’Fn boat. You’re not flushing me out! Check the recent 13Fs and 13Gs…big boys all loading up!
7
fgggggggg
$PHAT I wonder if they will do an announcement when they cross 2m prescriptions. Would be about now, no?
7
Joe_90_
$PHAT Folks, from the wise man Mr. David Paul (RIP), the best trades occur after the masses have been stopped out....if you don't have the strength or what he refers jokingly to as testicular fortitude to buy at that level, The good trade is always emotionally difficult, because it requires patience, discomfort and the ability to act when most traders cannot.
6
Bogy99
$PHAT but but but Steve is doing such a great job!! We can do 1B, no make that 2B in sales. We just have to cut guidance first , then we can get there. It’s just temporary. Trust me. lol. Absolute used car salesman. He better hit any bid he gets (after he speaks with the sales manager of course )!
5
Valueforall
$PHAT ok mudhaphukkas!!!!!! I am ready to blow my last and final BIG load on this biznitch! sorry just chiming in my inner Nitin I have huge orders in at just below $8 come and get em...jsut put a mid sizing order here at $8 just in case so I dont get fomo's by the MM mofos!
1
2
pfh_investing
$PHAT Volume has a spike at open; almost nothing all day; then generally a much larger spike of usually buyers right around closing. Seems to be finding a nice floor and I continue to load up sub $9 Revs of $300M and growing and market cap $650-750M and about to be cash flowing = relatively low risk bet and at some point too cheap not too be a takeover target.
5
Valueforall
$PHAT need to come up with the unexpected plan of making purchases in $6.xx area tomorrow. And I thought trying to get $7.9x was hopeful!
2
Fire7878
$PHAT either the quant algos have this in free fall or a lot of people know something that hasnt publicly been disclosed.
4
longshot45
$PHAT Looks like stop loss hunting at open. Saw that premarket 2k at 7.93 dip. MMs stands for manipulating mothers smh
4
StardustTrader
$PHAT volume has went bye bye. Quietly popped back over the daily 20sma. Still on no mans land on weekly and monthly is curling. Good add zone still but unpredictable near term price action. Wouldn't blow your load here (certainly would not sell any)
4
pfh_investing
$PHAT new 52 week low on hilariously low volume 😂 200-300k shares traded so far today. Just not enough interested buyers coming in to scoop this up. 10 yr treasury spike is likely having an outsized short term impact as well. The closer this gets to $600M market cap the quicker this becomes a takeover target. +$300M annual revenue and growing quickly with $100M in the bank = incredibly cheap
3
StocktwitsNews
PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming Rival $PHAT $VTI $IWM https://stocktwits.com/news/equity/markets/phat-stock-falls-7-as-leerink-sees-little-near-term-upside-ceo-plays-down-upcoming-rival/cZt7al5RJzt
1
longshot45
$PHAT Someone trying to pick up 10k at 8.90 lol Algos were like nah. They did give me 5 of my 15 at 8.87 earlier though lol. As I said, if you get out, there is no guarantee you can get back in
3

Advertisement|Remove ads.